Searched for
TADALAFIL
Pleasure profits: Sex stimulants show enhanced performanceSales of sex stimulants and rejuvenators in India have surged by 17% over the past year, with significant gains in sildenafil and tadalafil...- Stocks in news: Indian Hotels, RailTel, Dr Lal PathLabs, Torrent Power, LupinRailTel received an order worth Rs 352 cr from BMC for supply, operations and maintenance of the health department of the corporation.
- Stocks in news: Tech Mahindra, Lemon Tree, Sula Vineyards, Punjab & Sind Bank, D-link IndiaThe Board of Titagarh Wagons is scheduled to meet on June 10 to consider and approve a proposal to raise funds by issue equity of shares or...
- Sun Pharma recalls over 1.10 lakh bottles of generic drug in US marketThe company is recalling 73,957 bottles of 5 mg strength and 36,786 bottles of 20 mg strength, the US health regulator stated. An affected ...
- Glenmark Pharma gets USFDA nod for erectile dysfunction treatmentGlenmark Pharmaceuticals Ltd has received final approval from the United States Food and Drug Administration (USFDA) for Tadalafil tablets ...
- Indian scientists identify new potential drug treatments for COVID-19Using a virtual screening of the DrugBank database, the research published in the journal Scientific Reports, identified a variety of as ye...
- Dr Reddy's launches erectile dysfunction treatment drug in USThe approved products is a therapeutic equivalent generic version of Cialis (tadalafil) tablets.
- Alembic Pharma gets USFDA nod for erectile dysfunction drugThe company currently has a total of 89 ANDA approvals (77 final approvals and 12 tentative approvals) from USFDA, it added.
- Stocks in the news: IIFL Holdings, Sun Pharma, Axis Bank, Coal India and BoschHere are a few stocks which may buzz the most in today’s trade.
- Dr Reddy's launches erectile dysfunction treatment drug in USTadalafil tablets are a therapeutic equivalent generic version of Adcirca tablets, Dr Reddy's Laboratories said in a BSE filing.
- Stocks in the news: RIL, Wipro, Tata Motors, Indiabulls Ventures and Axis BankHere's a look at the top stocks that may hog the limelight in today's session.
- Drug eTailers face traditional pharma retailers’ wrath as policy evolvesFollowing the issuance of the draft guidelines by the government, stakeholders are expected to send their suggestions within a forty-five d...
- PMBJPs selling drugs up to 96% cheaper than branded equivalentsMandaviya, in a written reply in the Lok Sabha , said that the branded generic medicines are generally sold at higher prices in comparison ...
- Viagra sales go limp after flourishViagra and its numerous desi cousins have shown a minuscule growth of 5.43 per cent in sales. Fear of side-effects has hit sales
- Local pharma strikes first in patent warGlobal innovator pharma companies and domestic generic players are sparring with each other in the wake of India’s new product patent regim...
Load More
